OM
MBX

Opaleye Management’s MBX Biosciences MBX Stock Holding History

Opaleye Management’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.76M Hold
260,000
– – 1.02% 25
2025
Q4 		$8.2M Buy
260,000
+7,000
+3% +$170K 1.08% 22
2025
Q3 		$4.43M Buy
253,000
+13,681
+6% +$183K 0.63% 30
2025
Q2 		$2.73M Sell
239,319
-10,681
-4% -$109K 0.55% 29
2025
Q1 		$1.84M Buy
+250,000
New +$2.64M 0.41% 34

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Opaleye Management's MBX Position: Q1 2026 in Review

Opaleye Management held its MBX Biosciences (MBX) position steady in Q1 2026 at 260,000 shares worth $7.76M. The position accounts for 1.02% of the portfolio, ranked #25.

Opaleye Management first reported a position in MBX in Q1 2025 and has held it in 5 quarters since. The position peaked at $8.2M in Q4 2025. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • Opaleye Management held 260,000 shares of MBX Biosciences worth $7.76M as of Q1 2026.
  • Opaleye Management left its MBX Biosciences share count unchanged in Q1 2026.
  • MBX Biosciences made up 1.02% of Opaleye Management's portfolio in Q1 2026, its #25 holding.
  • Opaleye Management first reported a position in MBX Biosciences in Q1 2025 and has held it in 5 quarters since.
  • Opaleye Management's MBX Biosciences position peaked at $8.2M in Q4 2025.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on Opaleye Management's 13F filing for Q1 2026, filed 15 May 2026.